ContractVersion Stock Purchase Agreement This Agreement • May 5th, 2020 • New York
EX-10.2 5 v207772_ex10-2.htm Exhibit 10.2 EXECUTION VERSION STOCK PURCHASE AGREEMENT This Agreement (“Agreement”) is made and entered into as of January 6, 2011 (the “Effective Date”), by and among ZIOPHARM Oncology, Inc., a Delaware corporation (the “Company”), and Intrexon Corporation, a Virginia corporation (“Intrexon”). A. Concurrently with the execution of this Agreement, the Company is entering into a Channel Partner Agreement with Intrexon (the “Channel Agreement”), pursuant to which Intrexon is licensing the rights to certain technology to the Company; and B. In partial consideration of Intrexon’s license under the Channel Agreement, the Company has agreed to issue and sell to Intrexon certain shares of the Company’s common stock in accordance with the terms and conditions of this Agreement. C. In connection with the entry into the Channel Agreement, the Company has also agreed to issue and sell to Intrexon, and Intrexon has agreed to purchase from the Company, certain shares o
